DIFFERENCES IN DRUG-METABOLISM POLYMORPHISM BETWEEN ORIENTALS AND CAUCASIANS

[1] Agarwal D P, 1986, Prog Clin Biol Res, V214, P99

[2] PHARMACOGENETIC STUDY WITH DIAZEPAM IN TWINS [J]. NEUROPSYCHOBIOLOGY, 1987, 17 (1-2) : 4 - 8

[3] ALVAN G, 1982, LANCET, V1, P333

[4] METABOLIC OXIDATION PHENOTYPES AS MARKERS FOR SUSCEPTIBILITY TO LUNG-CANCER [J]. NATURE, 1984, 312 (5990) : 169 - 170

[5] IMPORTANCE OF GENETIC-FACTORS IN THE REGULATION OF DIAZEPAM METABOLISM - RELATIONSHIP TO S-MEPHENYTOIN, BUT NOT DEBRISOQUIN, HYDROXYLATION PHENOTYPE [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (04) : 348 - 355

[6] BOCHNER F, 1983, HDB CLIN PHARM

[7] HUMAN CYTOCHROMES-P-450 [J]. XENOBIOTICA, 1984, 14 (1-2) : 151 - 185

[8] BROSEN K, 1985, ACTA PHARMACOL TOX, V57, P357

[9] BUHLEN R, 1984, ALCOHOLISM, V2, P47

[10] CHEN R, 2ND INT ISSX M, P111

[1] Agarwal D P, 1986, Prog Clin Biol Res, V214, P99

[2] PHARMACOGENETIC STUDY WITH DIAZEPAM IN TWINS [J]. NEUROPSYCHOBIOLOGY, 1987, 17 (1-2) : 4 - 8

[3] ALVAN G, 1982, LANCET, V1, P333

[4] METABOLIC OXIDATION PHENOTYPES AS MARKERS FOR SUSCEPTIBILITY TO LUNG-CANCER [J]. NATURE, 1984, 312 (5990) : 169 - 170

[5] IMPORTANCE OF GENETIC-FACTORS IN THE REGULATION OF DIAZEPAM METABOLISM - RELATIONSHIP TO S-MEPHENYTOIN, BUT NOT DEBRISOQUIN, HYDROXYLATION PHENOTYPE [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (04) : 348 - 355

[6] BOCHNER F, 1983, HDB CLIN PHARM

[7] HUMAN CYTOCHROMES-P-450 [J]. XENOBIOTICA, 1984, 14 (1-2) : 151 - 185

[8] BROSEN K, 1985, ACTA PHARMACOL TOX, V57, P357

[9] BUHLEN R, 1984, ALCOHOLISM, V2, P47

[10] CHEN R, 2ND INT ISSX M, P111